Lastly, ACD and TERF2IP, as well as TERT promoter variants, are associated not only with early onset and multiple CM, but also with other cancers, although these latter associations are not yet conclusively defined [12]. This evidence concerns the gene TERF2IP and cutaneous mastocytosis.